--- title: "Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Monday" description: "U.S. stocks rose on Monday, with the Dow Jones gaining over 100 points. Sarepta Therapeutics shares surged 9.8% after positive results from its Phase 3 study of Elevidys for Duchenne muscular dystroph" type: "news" locale: "en" url: "https://longbridge.com/en/news/273730798.md" published_at: "2026-01-26T17:05:33.000Z" --- # Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Monday > U.S. stocks rose on Monday, with the Dow Jones gaining over 100 points. Sarepta Therapeutics shares surged 9.8% after positive results from its Phase 3 study of Elevidys for Duchenne muscular dystrophy. Lands' End jumped 38.8% following a joint venture announcement. Other notable gainers included Alpha Technology Group (+26.8%), Rich Sparkle Holdings (+22%), and TRX Gold (+18%). Precious metals stocks rose amid safe-haven demand due to geopolitical concerns. USA Rare Earth climbed 14.3% after a funding announcement with the U.S. government. CoreWeave gained 9.5% after expanding its collaboration with Nvidia. U.S. stocks were higher, with the Dow Jones gaining over 100 points on Monday. Shares of **Sarepta Therapeutics Inc** (NASDAQ:SRPT) rose sharply during Monday's session after the company released topline three-year functional results from Part 1-treated patients in the EMBARK (Study SRP-9001-301) Phase 3 study of Elevidys (delandistrogene moxeparvovec-rokl) in ambulatory individuals with Duchenne muscular dystrophy. Three years after treatment, patients who received Elevidys in Part 1 of EMBARK demonstrated statistically significant, clinically meaningful, and durable efficacy across all key motor function measures, North Star Ambulatory Assessment (NSAA), Time to Rise (TTR), and 10-meter walk/run (10MWR), when compared to a pre-specified propensity-weighted untreated external control group. Sarepta Therapeutics shares jumped 9.8% to $23.20 on Monday. Here are some other big stocks recording gains in today’s session. - **Lands’ End Inc** (NASDAQ:LE) shares jumped 38.8% to $19.51 after the company announced an agreement to form a new joint venture with WHP Global unlock the value of Lands’ End’s intellectual property. - **Alpha Technology Group Ltd** (NASDAQ:ATGL) gained 26.8% to $23.61. - **Rich Sparkle Holdings Ltd** (NASDAQ:ANPA) gained 22% to $64.66. - **TRX Gold Corp** (NYSE:TRX) gained 18% to $1.34. Shares of precious metals traded higher as investors seek safe-haven assets after President Trump recently announced he would impose a 100% tariff on Canada, and concerns about a partial government shutdown if a deal is not reached by Friday’s deadline. - **Northern Dynasty Minerals Ltd** (NYSE:NAK) rose 18% to $2.54. Shares of rare-earth mineral stocks traded higher amid sympathy with USA Rare Earth after the Trump administration acquired a 10% stake in the company. - **GoldMining Inc** (NYSE:GLDG) shares jumped 17.4% to $2.22. Shares of precious metals traded higher as investors seek safe-haven assets after President Trump recently announced he would impose a 100% tariff on Canada, and concerns about a partial government shutdown if a deal is not reached by Friday’s deadline. - **Greenwich Lifesciences Inc** (NASDAQ:GLSI) shares surged 14.4% to $29.15. The company last week announced the Food and Drug Administration approved the use of its first commercially manufactured GP2 lot for the FLAMINGO-01 Phase III clinical trial. - **USA Rare Earth Inc** (NASDAQ:USAR) shares climbed 14.3% to $28.31 after the company announced a non-binding letter of intent with the U.S. government for access to $1.6 billion in funding to accelerate the domestic rare earth value chain. - **Zoom Communications Inc** (NASDAQ:ZM) gained 10.5% to $94.83. - A**lmonty Industries Inc** (NASDAQ:ALM) shares rose 10.2% to $12.24. - **Cloudflare In**c (NYSE:NET) shares climbed 10.2% to $191.11 amid a broader market rally. - **CoreWeave Inc** (NASDAQ:CRWV) gained 9.5% to $101.88 after the company announced an expanded collaboration with **Nvidia Corporation** (NASDAQ:NVDA) to accelerate the buildout of more than 5 gigawatts of AI factories by 2030 to advance AI adoption at global scale. Photo via Shutterstock ### Related Stocks - [LE.US - Lands End](https://longbridge.com/en/quote/LE.US.md) - [ARKG.US - Ark Genomic Revolution ETF](https://longbridge.com/en/quote/ARKG.US.md) - [IBBQ.US - Invesco Nasdaq Biotechnology ETF](https://longbridge.com/en/quote/IBBQ.US.md) - [IXJ.US - iShares Global Healthcare](https://longbridge.com/en/quote/IXJ.US.md) - [VHT.US - VG Health](https://longbridge.com/en/quote/VHT.US.md) - [USARW.US - USA Rare Earth - CW300313](https://longbridge.com/en/quote/USARW.US.md) - [TRX.US - TRX Gold](https://longbridge.com/en/quote/TRX.US.md) - [BBH.US - VanEck Biotech ETF](https://longbridge.com/en/quote/BBH.US.md) - [DJD.US - Guggenheim DJIA Ave Div](https://longbridge.com/en/quote/DJD.US.md) - [PBE.US - Invesco Biotechnology & Genome ETF](https://longbridge.com/en/quote/PBE.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | US business, consumers bore 90 percent of Trump tariff costs: NY Fed | U.S. businesses and consumers have borne approximately 90% of the costs associated with President Trump’s tariffs, accor | [Link](https://longbridge.com/en/news/275922363.md) | | USA Rare Earth Shifts From Funding Story To Execution With U.S. Backing | USA Rare Earth has partnered with the U.S. government for significant funding, including an equity stake, to develop a d | [Link](https://longbridge.com/en/news/276013052.md) | | FDA Clears Precision BioSciences to Begin Clinical Trial for Duchenne Muscular Dystrophy Therapy | Precision BioSciences Inc. has received FDA clearance to begin clinical trials for its gene editing therapy, PBGENE-DMD, | [Link](https://longbridge.com/en/news/275600705.md) | | Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here? | Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here? | [Link](https://longbridge.com/en/news/276273938.md) | | Merit Financial Group LLC Buys 1,397 Shares of Regeneron Pharmaceuticals, Inc. $REGN | Merit Financial Group LLC increased its stake in Regeneron Pharmaceuticals, Inc. by 302.4% in Q3, acquiring 1,397 additi | [Link](https://longbridge.com/en/news/276208818.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.